ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Texas Death Row Inmate and Prosecutor Jointly Urge U.S. Supreme Court to Vacate Capital Conviction Based on Faulty DNA Evidence

Tomorrow, Texas death row inmate Areli Escobar’s petition for a writ of certiorari will be distributed to the Justices of the U.S. Supreme Court, urging them to summarily reverse or grant full review of the Texas Court of Criminal Appeals’ decision upholding his capital conviction. The State of Texas has taken the unusual step of filing a response brief joining Mr. Escobar in seeking to have his conviction vacated, because it was secured based on DNA and other forensic evidence processed by a state lab that Texas closed after discovering failures so abject that the lab could not be salvaged. The relief that Mr. Escobar and Texas seek is supported by the American Bar Association, the Innocence Network and the Center for Integrity in Forensic Sciences, Inc. and former State Attorneys General, United States Attorneys, and state prosecutors from across the political and law-enforcement spectrum.

Mr. Escobar was convicted of capital murder in Texas state court largely based on false DNA evidence and sentenced to death. Because it was seemingly a stranger-on-stranger offense with no eyewitnesses, Texas acknowledges that it relied heavily on DNA and other forensic evidence to present its case. But the State later audited the lab that processed the forensic evidence presented during Mr. Escobar’s trial and discovered grave, systemic deficiencies at every level. The revelations prompted the criminal district judges of Travis County to send a joint letter to the Austin City Council, suggesting that the “problems discovered” by the State’s audit “raise questions about every determination made by the lab.”

Upon learning of the lab’s widely reported failures, Mr. Escobar filed an application for habeas relief. After taking evidence and testimony from both sides over the course of years, the Texas habeas court issued over 400 findings of fact and conclusions of law, determining that the DNA evidence used to convict Mr. Escobar was false, misleading, and unreliable, and was reasonably likely to have influenced the jury’s decision. Thus, the habeas court recommended that Mr. Escobar’s conviction be vacated. After the state habeas court issued its exhaustive decision, the District Attorney undertook a thorough review of the record and trial court proceedings, ultimately agreeing that Mr. Escobar’s federal due process rights were violated and that he is entitled to a new trial.

However, despite the agreement of Mr. Escobar, the prosecution, and the state habeas court, the Texas CCA denied relief in a terse, three-page opinion, holding that there is no reasonable likelihood that the false DNA evidence could have affected the jury’s judgment, without even acknowledging the prosecution’s contrary view.

Mr. Escobar filed a petition for a writ of certiorari, seeking summary reversal or, alternatively, plenary review. Three sets of prominent amici curiae with subject matter expertise, representing divergent viewpoints, filed amicus briefs supporting Mr. Escobar. The American Bar Association has taken the rare step of filing an amicus brief calling for summary reversal due to the mishandling of the DNA evidence in the case, which violated multiple ABA standards. The Innocence Network and the Center for Integrity in Forensic Sciences filed an amicus brief calling for summary reversal because the “jury relied” on “wholly unreliable” DNA evidence to convict Mr. Escobar, as well as shoe-print and latent fingerprint evidence that “was also unreliable.” And former State Attorneys General, United States Attorneys, and state prosecutors from across the political spectrum filed an amicus brief arguing for summary reversal because the Texas CCA “fail[ed] to give due regard to the prosecution’s confession of error.” Failing to reverse, according to these former law-enforcement officials, would be a “miscarriage of justice in this capital case.”

Perhaps most unusual, Texas filed a brief of respondent supporting Mr. Escobar’s petition, agreeing that the Supreme Court “should grant a writ of certiorari summarily reversing the judgment below and remanding, or, alternatively, for plenary review.” The State’s attorneys found “that the State had offered flawed and misleading forensic evidence at [Mr. Escobar’s] trial and this evidence was material to the outcome of his case in violation of clearly established federal due process law.” “In refusing to acknowledge the State’s admission of error, the CCA,” according to Texas, “undermined the District Attorney’s historical role in the criminal justice system and failed to remedy the federal due process violation that both parties and the District Court agreed occurred.”

Mr. Escobar filed his reply brief today, summarizing why the parties, habeas court, and prominent amici are all correct that his conviction should be vacated. He further explains that denying his petition would force him to seek federal habeas relief and subject him to standards that are by design much more difficult to meet—an unjust result, especially since all the parties and distinguished amici agree that relief is so clearly warranted.

The case is Escobar v. Texas, No. 21-1601 (U.S.). The Supreme Court Clerk’s Office will distribute the petition tomorrow, and the Justices will consider at their October 28, 2022 conference whether to grant the relief that all parties and amici seek.

Contact Information:

Name: Daniel Woofter
Email: dhwoofter@goldsteinrussell.com
Job Title: Counsel of Record

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.